Cardlytics (NASDAQ:CDLX) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.24) by 37.5 percent. The company reported quarterly sales of $67.100 million which beat the analyst consensus estimate of $57.791 million by 16.11 percent. This is a 15.07 percent decrease over sales of $79.005 million the same period last year.